656 related articles for article (PubMed ID: 15034867)
21. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
[No Abstract] [Full Text] [Related]
22. [The different signal patterns of two FISH probes in the FISH detection of Ph-positive leukemia and their clinical significance].
Jiang H; Xue YQ; Pan JL; Zhang J; Dai HP; Wu YF; Wang Y; Shen J; Chen SN
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):166-70. PubMed ID: 20376798
[TBL] [Abstract][Full Text] [Related]
23. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
Xue YQ
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
[TBL] [Abstract][Full Text] [Related]
24. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia.
Cirmena G; Aliano S; Fugazza G; Bruzzone R; Garuti A; Bocciardi R; Bacigalupo A; Ravazzolo R; Ballestrero A; Sessarego M
Cancer Genet Cytogenet; 2008 Jun; 183(2):105-8. PubMed ID: 18503828
[TBL] [Abstract][Full Text] [Related]
25. [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
Usui N
Rinsho Byori; 2004 Feb; 52(2):136-44. PubMed ID: 15027317
[TBL] [Abstract][Full Text] [Related]
26. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
[TBL] [Abstract][Full Text] [Related]
27. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
[TBL] [Abstract][Full Text] [Related]
28. The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia.
Vigorito AC; Lorand-Metze I; Chauffaile ML; Costa FF; Saad ST
Haematologia (Budap); 1998; 29(2):123-32. PubMed ID: 9728804
[TBL] [Abstract][Full Text] [Related]
29. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.
Bousquet M; Quelen C; De Mas V; Duchayne E; Roquefeuil B; Delsol G; Laurent G; Dastugue N; Brousset P
Oncogene; 2005 Nov; 24(48):7248-52. PubMed ID: 16091753
[TBL] [Abstract][Full Text] [Related]
30. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
[TBL] [Abstract][Full Text] [Related]
32. bcr genes and transcripts.
Lifshitz B; Fainstein E; Marcelle C; Shtivelman E; Amson R; Gale RP; Canaani E
Oncogene; 1988 Feb; 2(2):113-7. PubMed ID: 3285291
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion.
Tirado CA; Sebastian S; Moore JO; Gong JZ; Goodman BK
Cancer Genet Cytogenet; 2005 Feb; 157(1):74-7. PubMed ID: 15676152
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of variant translocations in chronic myelogenous leukemia.
Verma RS; Macera MJ; Benn P; Groffen J
Oncogene; 1989 Sep; 4(9):1145-8. PubMed ID: 2674857
[TBL] [Abstract][Full Text] [Related]
35. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
36. bcr gene rearrangement analysis in myeloproliferative disorders other than chronic myelogenous leukemia.
Crisan D; Mattson JC; O'Malley BA; Schulz RW; Wilner F
Cancer Detect Prev; 1996; 20(4):263-9. PubMed ID: 8818385
[TBL] [Abstract][Full Text] [Related]
37. Different patterns of chromosome and molecular breakage in classic Ph1 chronic myelogenous leukemia (CML) and variant Ph1 CML.
Koduru P; Goh JC; Allen SL; Karp L; Jasti H; DeMarco LC; Lichtman SM
Hematol Pathol; 1991; 5(2):57-66. PubMed ID: 1894583
[TBL] [Abstract][Full Text] [Related]
38. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
[TBL] [Abstract][Full Text] [Related]
39. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
Morris CM
Methods Mol Biol; 2011; 730():33-61. PubMed ID: 21431633
[TBL] [Abstract][Full Text] [Related]
40. A variant t(8;10;21) in a patient with pathological features mimicking atypical chronic myeloid leukemia.
Lee J; Kern WF; Cain JB; Mulvihill JJ; Li S
Cancer Genet Cytogenet; 2005 May; 159(1):79-83. PubMed ID: 15860363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
